Understand the source comparison
Best Peptides for Liver Detoxification: Mechanism Comparison
Thymalin T-cell receptor modulation, reduces IL-6/TNF-alpha hepatic inflammation 5–10mg, 2–3x weekly, 4–8 week cycles Rodent NAFLD models show 41% reduction in inflammatory infiltrates (Molecular Medicine Reports, 2023) Best-supported immune modulation pathway
No winner is assigned.
This page preserves a source comparison for education. It does not add a rating, recommendation or clinical judgment.
- Thymalin
- T-cell receptor modulation, reduces IL-6/TNF-alpha hepatic inflammation
- 5–10mg, 2–3x weekly, 4–8 week cycles
- Rodent NAFLD models show 41% reduction in inflammatory infiltrates (Molecular Medicine Reports, 2023)
- Best-supported immune modulation pathway; requires baseline inflammatory markers (CRP, IL-6) to assess response
- Epitalon
- Telomerase activation, SIRT1 upregulation, hepatocyte autophagy
- 10mg daily, 10-day cycles, repeated monthly
- Reduces collagen deposition 28–35% in rodent fibrosis models; extends hepatocyte replicative capacity
- Strong mechanistic rationale for fibrosis prevention; limited human trials; mechanism suggests long-term use required
- BPC-157
- VEGF pathway modulation, angiogenesis in fibrotic tissue, reduces necrosis
- 250–500mcg daily, continuous or 4-week cycles
- Reduced CCl4-induced necrosis by 52%, normalized ALT/AST in 14 days (Pharmacological Research, 2022)
- Strongest acute hepatoprotection data; vascular mechanism orthogonal to immune/autophagy pathways. Synergistic potential
- Selank
- Anxiolytic peptide with secondary IL-6 reduction, stress-induced hepatic inflammation
- 250–500mcg daily, intranasal or subcutaneous
- Reduces stress-induced cortisol and secondary inflammatory markers; no direct hepatocyte trials
- Indirect benefit through HPA axis modulation; useful for stress-related NAFLD progression, not primary hepatoprotection